From this analysis, we were able to incorporate 2 out of 3 suppressive markers from our panel and identify a cluster of patients whose tumor demonstrated both low CD8+:FoxP3+ and low CD8+:PD-L1+ ratios (Fig. 5); and we failed to generate TIL from these tumors. Here, FOXP3 is linked to neoplasm.